ONCTERNAL THERAPEUTICS INC - COM (ONCT)

CUSIP: 68236P107

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
11,386,807
Share change
-1,980,530
Total reported value
$12,630,616
Put/Call ratio
28%
Price per share
$1.11
Number of holders
67
Value change
-$2,605,738
Number of buys
34
Number of sells
44

Quarterly Holders Quick Answers

What is CUSIP 68236P107?
CUSIP 68236P107 identifies ONCT - ONCTERNAL THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCTERNAL THERAPEUTICS INC - COM (ONCT) as of Q2 2022

As of 30 Jun 2022, ONCTERNAL THERAPEUTICS INC - COM (ONCT) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,386,807 shares. The largest 10 holders included VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, CITADEL ADVISORS LLC, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, Quantum Private Wealth, LLC, MORGAN STANLEY, BIT Capital GmbH, GEODE CAPITAL MANAGEMENT, LLC, and BRIGHTON JONES LLC. This page lists 67 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.